Fear of Price Caps Sank India’s Hospital Stocks, Now They Are Up

Concerns about government limits on medicine pricing hit hospital shares hard in recent weeks. Steady September-quarter results have now led to the sector’s strongest day in months, led by Max Healthcare.

Hospital stocks had their strongest day in months on Monday.

Max Healthcare closed at ₹1,009.90 on the NSE, up 6.63%, and was the Nifty 50’s best performer. Fortis Healthcare gained 5.13% to ₹803.20, Aster DM Healthcare rose 3.81% to ₹750, and Apollo Hospitals climbed 2.87% to ₹8,771. KIMS (Krishna Institute of Medical Sciences) rose about 5% during the day to ₹763.20. Trading volumes were heavy across the sector.

The rally followed weeks of selling.

Hospital shares fell in recent months because investors feared the government would regulate how hospitals price medicines.

The worry intensified in September, when the Supreme Court questioned the Centre during a hearing about a uniform 16% markup on medicines. It also asked about hospitals requiring patients to buy medicines from in-house pharmacies or specified chemists.

Investors remembered what happened in 2017 and 2019, when price caps on stents, knee implants and some medicines reduced hospital earnings almost immediately.

Pharmacy and consumables account for a meaningful share of revenue and profit at large hospital chains, so limits on markups would hurt. Max Healthcare hit a 52-week low of ₹797 on 22 October. From there to Monday’s close, it has risen about 27% (our calculation).

The results show upticks

The September-quarter numbers did not suggest a sector under pressure.

At Max Healthcare, operating EBITDA rose 18% from a year earlier to ₹820 crore, and reported net profit rose 10% to ₹448 crore. The EBITDA margin recovered to 26.8%, up 200 basis points from the June quarter. New hospitals take time to fill beds and usually reduce margins in their early months, so the margin recovery suggests those new units are starting to contribute.

Aster DM, which has merged with Quality Care India, reported revenue growth of 19% and operating EBITDA growth of 25%. KIMS signed an operations and management agreement for the 250-bed Westfort Hi-Tech Hospital in Thrissur, Kerala. This asset-light model lets a chain add beds without spending heavily on construction.

Are hospitals defensive?

There was a second reason for Monday’s buying. The market is nervous about AI stocks, interest rates and global growth. Taiwan fell more than 6% on the same day. Investors tend to move to sectors where demand does not depend on the economic cycle, and healthcare is one of them. Monday’s other big gainers were FMCG companies such as ITC, Tata Consumer and Nestle India, which supports that reading.

Demand for hospital care in India is also growing for structural reasons. The population is ageing, chronic diseases are more common, insurance coverage is expanding, and India still has fewer hospital beds per person than most large economies. Listed chains are adding thousands of beds over the next few years.

The risk remains

The pricing question has not been settled. The Supreme Court matter is still pending, and the government has not said whether it will act on hospital medicine markups. A ruling or new rule could bring the selling back quickly.

Valuations are another consideration. Hospital stocks have historically traded at high multiples because their growth is predictable. A rally of more than 25% from October lows reduces the margin of safety if the regulatory news turns negative.

For now, the sector’s results have reassured investors.

About The Author

Recommended For You

About the Author: Faiyaz Hardwarewala